SBIR-STTR Award

High Sensitivity, Low Complexity, Multiplexed Diagnostic Devices
Award last edited on: 3/31/2023

Sponsored Program
SBIR
Awarding Agency
DOD : CBD
Total Award Amount
$2,532,547
Award Phase
2
Solicitation Topic Code
CBD152-005
Principal Investigator
John C Carrano

Company Information

Paratus Diagnostics LLC

Po 160593 78716
Austin, TX 78716
   (512) 245-1050
   N/A
   www.paratusdiagnostics.com
Location: Single
Congr. District: 25
County: Travis

Phase I

Contract Number: HDTRA1-16-P-0048
Start Date: 8/29/2016    Completed: 8/31/2017
Phase I year
2016
Phase I Amount
$149,394
Infectious diseases have been a constant cause of non-battlefield injury and illness for military personnel engaged in operations throughout the world. Detection of these infectious pathogens is critical to proper patient care and management of outbreaks, yet many existing diagnostic tests fail to provide adequate sensitivity and/or simplicity for use in forward locations or in isolated areas. We propose to develop a solution for a high-sensitivity, low-complexity multiplexed POC diagnostic testing that addresses and resolves each of these challenges through the application or our unique and differentiated technologies. At the heart of this concept is our patent pending Specimen Delivery System (Paratus SDS) that will allow for the acquisition of a relevant quantity of patient specimen (including swab, blood or urine) by a medic or other military personnel, perform sample preparation and deliver the sample on to a unique paper-based analytical device (PAD) integrated into the cartridge for multiplexed detection of diverse pathogens (viral, bacterial, and protozoan). A reusable mating adapter will extend functionality by magnetic specimen separation and concentration, as well as smartphone-based imaging and App-based notification of results to the warfigther that they have tested positive/negative for a particular condition that requires further medical evaluation.

Phase II

Contract Number: HDTRA1-18-C-0004
Start Date: 11/6/2017    Completed: 11/5/2019
Phase II year
2018
(last award dollars: 2020)
Phase II Amount
$2,383,153

Our goal is to provide the Department of Defense with a reliable, point-of-need diagnostic device that is field-deployable, appropriatelysensitive, and can be easily adapted for detection of a variety of biological targets that are of interest to the defense community. Phase I of thisproject was for the initial demonstration and development of our low-cost personal diagnostic platform (referred to as the PreparedNowsystem) for detection of two gastrointestinal (GI) pathogens. In Phase II we propose to advance the system by increasing the number and typeof GI pathogens detected and performing pre-clinical tests of our end-to-end solution.